IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 67
Titolo Data di pubblicazione Autore(i) File
Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: A 9-year follow-up study 1-gen-2011 Mckie, Paul M.; Cataliotti, Alessandro; Sangaralingham, S. Jeson; Ichiki, Tomoko; Cannone, Valentina; Bailey, Kent R.; Redfield, Margaret M.; Rodeheffer, Richard J.; Burnett Jr., John C.
MANP: A Novel Designer Natriuretic Peptide for Cardiometabolic Disease 1-gen-2012 Cannone, Valentina; Huntley, Brenda K.; Heublein, Denise M.; Sandberg, Sharon M.; Harders, Gerald E.; Sangaralingham, Jeson S.; Martin, Fernando L.; Burnett, John C.
The atrial natriuretic peptide genetic ariant rs5068 is associated with a favorable cardiometabolic phenotype in a mediterranean population 1-gen-2013 Cannone, Valentina; Cefalu, Angelo Baldassare; Noto, Davide; Scott, Christopher G.; Bailey, Kent R.; Cavera, Giovanni; Pagano, Michele; Sapienza, Michelangelo; Averna, Maurizio R.; Burnett Jr., John C.
Aldosterone in the General Community: Biomarker or Mediator of Cardiorenal and Metabolic Disease 1-gen-2013 Buglioni, Alessia; Cannone, Valentina; Cataliotti, Alessandro; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Rodeheffer, Richard J.; Sarzani, Riccardo; Burnett, John C.
Aldosterone, Cardiorenal and Metabolic Disease in a General Community in Olmsted County, Minnesota: Biomarker and/or Mediator 1-gen-2013 Buglioni, A; Cannone, V; Cataliotti, A; Heublein, Dm; Scott, Cg; Bailey, Kr; Rodeheffer, Rj; Sarzani, R; Burnett, Jc
Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: A 9-year follow-up study 1-gen-2013 Cannone, Valentina; Huntley, Brenda K.; Olson, Timothy M.; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Redfield, Margaret M.; Rodeheffer, Richard J.; Burnett, John C.
The ANP Genetic Variant rs5068 Is Associated with Higher Circulating Concentrations of Natriuretic Peptides in Patients with Chronic Heart Failure 1-gen-2013 Cannone, Valentina; Barlera, Simona; Pileggi, Silvana; Masson, Serge; Franzosi, Maria Grazia; Latini, Roberto; Scardulla, Cesare; Clemenza, Francesco; Maggioni, Aldo P.; Nicolosi, Gian Luigi; Tavazzi, Luigi; Burnett, John C.
MANP: A novel designer natriuretic peptide GC-A activator for the treatment of hypertension and heart failure 1-gen-2014 Puccia, G.; Cannone, V.; Mckie, P. M.; Burnett, J. C.
Aldosterone Level in the General Community Predicts New Onset Cardiometabolic Disease 1-gen-2014 Buglioni, A; Cannone, V; Sangaralingham, Sj; Heublein, Dm; Scott, Cg; Bailey, Kr; Rodeheffer, Rj; Sarzani, R; Burnett, Jc
The Anp genetic variant Rs5068 and circulating levels of natriuretic peptides in patients with chronic heart failure 1-gen-2014 Cannone, Valentina; Barlera, Simona; Pileggi, Silvana; Masson, Serge; Franzosi, Maria Grazia; Latini, Roberto; Scardulla, Cesare; Clemenza, Francesco; Maggioni, Aldo P.; Nicolosi, Gian Luigi; Tavazzi, Luigi; Burnett, John C.
CHARACTERIZATION OF ANP GENETIC VARIANT RS5068 IN CHRONIC HEART FAILURE PATIENTS 1-gen-2014 Pileggi, S; Barlera, S; Cannone, V; Masson, S; Latini, R; Scardulla, C; Clemenza, F; Maggioni, Ap; Nicolosi, Gl; Tavazzi, L; Burnett, Jc; Franzosi, Mg
The Soluble Guanylate Cyclase Genetic Variant rs13139571 Is Associated with an “Unfavorable” Metabolic Phenotype in an US General Community 1-gen-2014 Cannone, Valentina; Scott, Christopher G.; Bailey, Kent R.; Olson, Timothy M.; Theis, Jeanne L.; Redfield, Margaret M.; Rodeheffer, Richard J.; Burnett, John C.
Aldosterone: Marker and Predictor of Cardiorenal and Metabolic Disease in the General Community 1-gen-2014 Buglioni, Alessia; Cannone, Valentina; Sangaralingham, S. Jeson; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Rodeheffer, Richard J.; Sarzani, Riccardo; Burnett, John C.
Circulating aldosterone predicts future cardiorenal and metabolic disease in the general community 1-gen-2015 Buglioni, A; Cannone, V; Sangaralingham, Sj; Scott, Cg; Bailey, Kr; Rodeheffer, Rj; Sarzani, R; Burnett, Jc
Plasma Aldosterone and Heart Failure in the General Community 1-gen-2015 Buglioni, A; Cannone, V; Sangaralingham, Js; Scott, Cg; Rodeheffer, Rj; Burnett, Jc
A cardiometabolic protective phenotype associated with the ANP genetic variant rs5068 in African Americans: the Multi-Ethnic Study of Atherosclerosis (MESA) 1-gen-2015 Cannone, V; Decker, Pa; Larson, Nb; Scott, Cg; Palmas, W; Taylor, Kd; Bielinski, Sj; Burnett, Jc
Aldosterone predicts cardiovascular, renal, and metabolic disease in the general community: A 4-year follow-up 1-gen-2015 Buglioni, Alessia; Cannone, Valentina; Sangaralingham, S. Jeson; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Rodeheffer, Richard J.; Sarzani, Riccardo; Burnett, John C.
Circulating cGMP Levels in the General Population: Relationship with Cardiovascular and Renal Diseases 1-gen-2015 Cannone, Valentina; Scott, Christopher G.; Bailey, Kent R.; Heublein, Denise M.; Redfield, Margaret M.; Rodeheffer, Richard J.; Stasch, Johannes-Peter; Burnett, John C.
Circulating aldosterone and natriuretic peptides in the general community relationship to cardiorenal and metabolic disease 1-gen-2015 Buglioni, Alessia; Cannone, Valentina; Cataliotti, Alessandro; Jeson Sangaralingham, S.; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Rodeheffer, Richard J.; Dessì-Fulgheri, Paolo; Sarzani, Riccardo; Burnett, John C.
Circulating cGMP plasma levels in cardiovascular and renal diseases: new insights from the general community 1-gen-2016 Cannone, V; Scott, Cg; Bailey, Kr; Heublein, Dm; Redfield, Mm; Rodeheffer, Rj; Stasch, Jp; Burnett, JC Jr
Mostrati risultati da 21 a 40 di 67
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile